 | | | | | | |
 | 2017 |
| |
  | 01 |
| |
| | 01/23/2017 | 02:00 PM | | Merck KGaA, Darmstadt, Germany, Announces Research Collaboration with Domain Therapeutics in Immuno-Oncology | |  |
| | 01/19/2017 | 08:00 AM | | Innovation Award for Organic Photovoltaics at the BAU 2017 | |  |
| | 01/18/2017 | 02:00 PM | | MilliporeSigma Launches First Commercial Service to Predict Multiple Sources of DNA Damage | |  |
| | 01/17/2017 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Moves Executives Between Businesses and Group Functions | |  |
| | 01/17/2017 | 02:00 PM | | MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain | |  |
| | 01/13/2017 | 07:00 AM | | Merck KGaA, Darmstadt, Germany, Drives Business Opportunities in the U.S. to Foster Innovation Across all Three Business Sectors | |  |
| | 01/13/2017 | 02:00 PM | | MilliporeSigma Introduces New Calibration Kit for In Vitro Diagnostic Use | |  |
| | 01/12/2017 | 11:00 PM | | Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration Partnership | |  |
| | 01/11/2017 | 03:00 PM | | Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development Programs from Vertex and Becomes a Leader in DNA Damage and Repair | |  |
| | 01/10/2017 | 08:00 AM | | Merck KGaA, Darmstadt, Germany and CLEARink Displays Sign Development Agreement | |  |
| | 01/10/2017 | 02:00 PM | | MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe | |  |
| | 01/09/2017 | 02:00 PM | | EMD Serono and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration | |  |
| | 01/04/2017 | 02:30 PM | | MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testing | |  |
  | 02 |
| |
  | 03 |
| |
  | 04 |
| |
  | 05 |
| |
  | 06 |
| |
  | 07 |
| |
  | 08 |
| |
  | 09 |
| |
  | 10 |
| |
  | 11 |
| |
  | 12 |
| |
 | 2018 |
| |